The plain 200-day rule: halves the drops, gives up the growth
Failure type: works but not worth it. Verdict: mixed; not confirmed under its own pass rule.
The idea
After the 32-variant search was ruled out, we tried the simplest thing nobody had tuned: give each of 23 ETFs an equal slot, hold the slot while the fund's close is above its 200-day average, check monthly, otherwise sit in T-bills.
What we did
The rule, both windows (2017–2021 and 2022–2023), and the pass criteria were committed before the run, and it was run once. Pass rule per window: worst drop at most 60% of an equal-weight basket of the same 23 ETFs, and Sharpe not more than 0.10 below that basket. Both windows had to pass.
What happened
| Sharpe | Yearly return | Worst drop | |
|---|---|---|---|
| 2017–2021 | |||
| 200-day rule | 0.97 | 8.97% | 13.4% |
| Equal-weight basket | 0.85 | 9.04% | 17.7% |
| SPY buy and hold | 0.92 | 18.28% | 33.7% |
| 2022–2023 | |||
| 200-day rule | −0.05 | 3.28% | 6.1% |
| Equal-weight basket | −0.07 | 2.74% | 12.4% |
| SPY buy and hold | 0.12 | 4.26% | 22.1% |
- 2017–2021: fail. Worst drop was 0.76 of the basket's; the bar was 0.60.
- 2022–2023: pass. Worst drop was 0.49 of the basket's. The year stocks and bonds fell together.
Why it isn't worth it
It does cut the damage, especially in 2022-style markets. But in the 2017–2021 bull market it earned about half of SPY's return, and in 2022–2023 its Sharpe was still below SPY's. We did not adjust the pass rule after seeing this. It is the base for the one idea that survived.
Receipts: the rules were written down and committed before any run. 6 overlay and 6 control trials.
Research and education only. These are paper results from historical data on a limited set of funds. Not investment advice, not a recommendation, not a prediction. See Legal.